P

Inventor

GIORDANO TONY

US12 patents
⚠️ This page may combine multiple inventors who share the name “GIORDANO TONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MESSAGE PHARMACEUTICALS

5 patents
US6004749ADec 21, 1999

Method for identifying compounds affecting RNA/RNA binding protein interactions

MESSAGE PHARMACEUTICALS42 citations89
US6936432B2Aug 30, 2005

Bacterial RNase P proteins and their use in identifying antibacterial compounds

MESSAGE PHARMACEUTICALS37 citations88
US6872850B2Mar 29, 2005

Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs

MESSAGE PHARMACEUTICALS15 citations79
US6448007B1Sep 10, 2002

Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elements

MESSAGE PHARMACEUTICALS17 citations78
US7001924B2Feb 21, 2006

Inhibitors of RNase P proteins as antibacterial compounds

MESSAGE PHARMACEUTICALS11 citations76

GREIG NIGEL H

2 patents
US8546430B2Oct 1, 2013

Thalidomide analogs

GREIG NIGEL H2 citations60
US8853253B2Oct 7, 2014

Thalidomide analogs

GREIG NIGEL H0 citations50

BEARSDEN BIO INC

1 patent
US5859227AJan 12, 1999

RNA sequences which interact with RNA-binding proteins

BEARSDEN BIO INC54 citations94

MESSAGE PHARMACETICALS INC

1 patent
US6107029AAug 22, 2000

Universal method for detecting interactions between RNA molecules and RNA binding proteins

MESSAGE PHARMACETICALS INC57 citations92

US HEALTH

1 patent
US7973057B2Jul 5, 2011

Thalidomide analogs

US HEALTH30 citations91

MESSAGE PHARMACEUTICALS INC

1 patent
US6465176B1Oct 15, 2002

Method for identifying compounds RNA/RNA binding protein interactions

MESSAGE PHARMACEUTICALS INC19 citations84

GIORDANO TONY

1 patent
US9051566B2Jun 9, 2015

Post-transcriptional gene silencing using expressed double stranded RNA

GIORDANO TONY0 citations43